No Prescription |
 |
 | ||
|
Loette Alesse |
|
| ||
No Prescription » Prescription Drugs 10 » Loette Alesse This combination hormone medication is used to prevent pregnancy. It contains 2 hormones: a progestin and an estrogen. These hormones prevent pregnancy in 3 ways. One way is by preventing the release of an egg (ovulation). A second way is by changing the cervical mucus making it more difficult for an egg to meet sperm (fertilization). A third way is by changing the womb lining making it difficult for a fertilized egg to attach to the lining of the womb (implantation). A fertilized egg (embryo/unborn baby) needs to attach to the womb to receive blood and nutrients and continue to grow. If an embryo/unborn baby does not attach it cannot survive.Using this medication does not protect you or your partner against sexually transmitted diseases (e.g. HIV gonorrhea). Buy Loette Alesse and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Loette Alesse: Product Type: Prescription Drugs 10 Loette ( Alesse Aviane Lybrel Trifeme Generic Levonorgestrel/Ethinyl Estradiol) Loette (Alesse Aviane Lybrel Trifeme Generic Levonorgestrel/Ethinyl Estradiol) Alesse Aviane Lybrel Trifeme Generic Levonorgestrel/Ethinyl Estradiol 0.10/0.02mg Alesse Aviane Lybrel Trifeme Generic Levonorgestrel/Ethinyl Estradiol Loette
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
